Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Seasonal and Annual Source Appointment of Carbonaceous Ultrafine Particulate Matter (PM0.1) in Polluted California Cities.

Xue J, Xue W, Sowlat MH, Sioutas C, Lolinco A, Hasson A, Kleeman MJ.

Environ Sci Technol. 2019 Jan 2;53(1):39-49. doi: 10.1021/acs.est.8b04404. Epub 2018 Dec 10.

PMID:
30452867
2.

Comparison of efficacy of aminolaevulinic acid photodynamic therapy vs. adapalene gel plus oral doxycycline for treatment of moderate acne vulgaris-A simple, blind, randomized, and controlled trial.

Nicklas C, Rubio R, Cárdenas C, Hasson A.

Photodermatol Photoimmunol Photomed. 2019 Jan;35(1):3-10. doi: 10.1111/phpp.12413. Epub 2018 Jul 26.

PMID:
29993146
3.

Safety and efficacy of human embryonic stem cell-derived astrocytes following intrathecal transplantation in SOD1G93A and NSG animal models.

Izrael M, Slutsky SG, Admoni T, Cohen L, Granit A, Hasson A, Itskovitz-Eldor J, Krush Paker L, Kuperstein G, Lavon N, Yehezkel Ionescu S, Solmesky LJ, Zaguri R, Zhuravlev A, Volman E, Chebath J, Revel M.

Stem Cell Res Ther. 2018 Jun 6;9(1):152. doi: 10.1186/s13287-018-0890-5.

4.

Diagnosis of cirrhosis in patients with chronic hepatitis C genotype 4: Role of ABCB11 genotype polymorphism and plasma bile acid levels.

Besheer T, Arafa M, El-Maksoud MA, Elalfy H, Hasson A, Zalata K, Elkashef W, Elshahawy H, Raafat D, Elemshaty W, Elsayed E, Zaghloul H, Razek AA, El-Bendary M.

Turk J Gastroenterol. 2018 May;29(3):299-307. doi: 10.5152/tjg.2018.17570.

5.

Association between CD226 polymorphism and soluble levels in rheumatoid arthritis: Relationship with clinical activity.

Mosaad YM, El-Toraby EE, Tawhid ZM, Abdelsalam AI, Enin AF, Hasson AM, Shafeek GM.

Immunol Invest. 2018 Apr;47(3):264-278. doi: 10.1080/08820139.2018.1423570. Epub 2018 Jan 10.

PMID:
29319370
6.

GDP-L-fucose is required for boundary definition in plants.

Gonçalves B, Maugarny-Calès A, Adroher B, Cortizo M, Borrega N, Blein T, Hasson A, Gineau E, Mouille G, Laufs P, Arnaud N.

J Exp Bot. 2017 Dec 16;68(21-22):5801-5811. doi: 10.1093/jxb/erx402.

7.

Testing and linkage to HIV care in China: a cluster-randomised trial.

Wu Z, Tang Z, Mao Y, Van Veldhuisen P, Ling W, Liu D, Shen Z, Detels R, Lan G, Erinoff L, Lindblad R, Gu D, Tang H, Hu L, Zhu Q, Lu L, Oden N, Hasson AL, Zhao Y, McGoogan JM, Ge X, Zhang N, Rou K, Zhu J, Wei H, Shi CX, Jin X, Li J, Montaner JSG.

Lancet HIV. 2017 Dec;4(12):e555-e565. doi: 10.1016/S2352-3018(17)30131-5. Epub 2017 Aug 31.

PMID:
28867267
8.

A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.

Gray KM, Sonne SC, McClure EA, Ghitza UE, Matthews AG, McRae-Clark AL, Carroll KM, Potter JS, Wiest K, Mooney LJ, Hasson A, Walsh SL, Lofwall MR, Babalonis S, Lindblad RW, Sparenborg S, Wahle A, King JS, Baker NL, Tomko RL, Haynes LF, Vandrey RG, Levin FR.

Drug Alcohol Depend. 2017 Aug 1;177:249-257. doi: 10.1016/j.drugalcdep.2017.04.020. Epub 2017 Jun 10.

9.

Care cascade structural intervention versus standard of care in the diagnosis and treatment of HIV in China: a cluster-randomized controlled trial protocol.

Mao Y, Wu Z, McGoogan JM, Liu D, Gu D, Erinoff L, Ling W, VanVeldhuisen P, Detels R, Hasson AL, Lindblad R, Montaner JSG, Tang Z, Zhao Y.

BMC Health Serv Res. 2017 Jun 12;17(1):397. doi: 10.1186/s12913-017-2323-z.

10.

Self-reported substance use in Iraq: findings from the Iraqi National Household Survey of Alcohol and Drug Use, 2014.

Al-Hemiery N, Dabbagh R, Hashim MT, Al-Hasnawi S, Abutiheen A, Abdulghani EA, Al-Diwan JK, Kak N, Al Mossawi H, Maxwell JC, Brecht ML, Antonini V, Hasson A, Rawson RA.

Addiction. 2017 Aug;112(8):1470-1479. doi: 10.1111/add.13800. Epub 2017 Apr 7.

PMID:
28238214
11.

Compact MRI for the detection of teratoma development following intrathecal human embryonic stem cell injection in NOD-SCID mice.

Ramot Y, Schiffenbauer YS, Amouyal N, Ezov N, Steiner M, Izrael M, Lavon N, Hasson A, Revel M, Nyska A.

Neurotoxicology. 2017 Mar;59:27-32. doi: 10.1016/j.neuro.2017.01.003. Epub 2017 Jan 6.

PMID:
28069364
12.

When strength turns into disease: acne fulminans in a bodybuilder.

Perez M, Navajas-Galimany L, Antunez-Lay A, Hasson A.

An Bras Dermatol. 2016 Sep-Oct;91(5):706. doi: 10.1590/abd1806-4841.20165345. No abstract available.

13.

Loss to Follow-Up from HIV Screening to ART Initiation in Rural China.

Gu D, Mao Y, Tang Z, Montaner J, Shen Z, Zhu Q, Detels R, Jin X, Xiong R, Xu J, Ling W, Erinoff L, Lindblad R, Liu D, Van Veldhuisen P, Hasson A, Wu Z.

PLoS One. 2016 Oct 21;11(10):e0164346. doi: 10.1371/journal.pone.0164346. eCollection 2016.

14.

A bias in the "mass-normalized" DTT response - an effect of non-linear concentration-response curves for copper and manganese.

Charrier JG, McFall AS, Vu KK, Baroi J, Olea C, Hasson A, Anastasio C.

Atmos Environ (1994). 2016 Nov;144:325-334. Epub 2016 Sep 4.

15.

Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.

Ling W, Hillhouse MP, Saxon AJ, Mooney LJ, Thomas CM, Ang A, Matthews AG, Hasson A, Annon J, Sparenborg S, Liu DS, McCormack J, Church S, Swafford W, Drexler K, Schuman C, Ross S, Wiest K, Korthuis PT, Lawson W, Brigham GS, Knox PC, Dawes M, Rotrosen J.

Addiction. 2016 Aug;111(8):1416-27. doi: 10.1111/add.13375. Epub 2016 Apr 21.

16.

Sexual trauma in the military: Exploring PTSD and mental health care utilization in female veterans.

Kintzle S, Schuyler AC, Ray-Letourneau D, Ozuna SM, Munch C, Xintarianos E, Hasson AM, Castro CA.

Psychol Serv. 2015 Nov;12(4):394-401. doi: 10.1037/ser0000054.

PMID:
26524281
17.

Divide et impera: boundaries shape the plant body and initiate new meristems.

Wang Q, Hasson A, Rossmann S, Theres K.

New Phytol. 2016 Jan;209(2):485-98. doi: 10.1111/nph.13641. Epub 2015 Sep 22. Review.

18.

A conserved role for CUP-SHAPED COTYLEDON genes during ovule development.

Gonçalves B, Hasson A, Belcram K, Cortizo M, Morin H, Nikovics K, Vialette-Guiraud A, Takeda S, Aida M, Laufs P, Arnaud N.

Plant J. 2015 Aug;83(4):732-42. doi: 10.1111/tpj.12923. Epub 2015 Jul 23.

19.

Lateral suppressor and Goblet act in hierarchical order to regulate ectopic meristem formation at the base of tomato leaflets.

Rossmann S, Kohlen W, Hasson A, Theres K.

Plant J. 2015 Mar;81(6):837-48. doi: 10.1111/tpj.12782.

20.

Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study.

Teruya C, Schwartz RP, Mitchell SG, Hasson AL, Thomas C, Buoncristiani SH, Hser YI, Wiest K, Cohen AJ, Glick N, Jacobs P, McLaughlin P, Ling W.

J Psychoactive Drugs. 2014 Nov-Dec;46(5):412-26. doi: 10.1080/02791072.2014.921743.

21.

Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.

McClure EA, Sonne SC, Winhusen T, Carroll KM, Ghitza UE, McRae-Clark AL, Matthews AG, Sharma G, Van Veldhuisen P, Vandrey RG, Levin FR, Weiss RD, Lindblad R, Allen C, Mooney LJ, Haynes L, Brigham GS, Sparenborg S, Hasson AL, Gray KM.

Contemp Clin Trials. 2014 Nov;39(2):211-23. doi: 10.1016/j.cct.2014.08.011. Epub 2014 Aug 30.

22.

Drug and alcohol use in Iraq: findings of the inaugural Iraqi Community Epidemiological Workgroup.

Al-Hemiary NJ, Al-Diwan JK, Hasson AL, Rawson RA.

Subst Use Misuse. 2014 Nov;49(13):1759-63. doi: 10.3109/10826084.2014.913633. Epub 2014 May 14.

23.

Performance of commercial nonmethane hydrocarbon analyzers in monitoring oxygenated volatile organic compounds emitted from animal feeding operations.

Trabue S, Scoggin K, McConnell LL, Li H, Turner A, Burns R, Xin H, Gates RS, Hasson A, Ogunjemiyo S, Maghirang R, Hatfield J.

J Air Waste Manag Assoc. 2013 Oct;63(10):1163-72.

PMID:
24282968
24.

Topical photodynamic therapy with 5-aminolevulinate for the treatment of tumor-stage mycosis fungoides: a case report.

Hasson A, Navarrete-Dechent C, Nicklas C, Sazunic I.

Int J Dermatol. 2013 Dec;52(12):1535-7. doi: 10.1111/j.1365-4632.2011.05427.x. Epub 2013 Oct 18. No abstract available.

PMID:
24134456
25.

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.

Hser YI, Saxon AJ, Huang D, Hasson A, Thomas C, Hillhouse M, Jacobs P, Teruya C, McLaughlin P, Wiest K, Cohen A, Ling W.

Addiction. 2014 Jan;109(1):79-87. doi: 10.1111/add.12333. Epub 2013 Oct 9.

26.

Acquired telangiectatic plaque-like glomangioma on the forehead.

Farias MM, Kolbach M, Perez M, Gonzalez S, Hasson A.

Int J Dermatol. 2013 Jun;52(6):731-2. doi: 10.1111/j.1365-4632.2011.05323.x. No abstract available.

PMID:
23679879
27.

Efficacy of red light alone and methyl-aminolaevulinate-photodynamic therapy for the treatment of mild and moderate facial acne.

Pinto C, Schafer F, Orellana JJ, Gonzalez S, Hasson A.

Indian J Dermatol Venereol Leprol. 2013 Jan-Feb;79(1):77-82. doi: 10.4103/0378-6323.104673.

28.

A comparison of buprenorphine taper outcomes between prescription opioid and heroin users.

Nielsen S, Hillhouse M, Thomas C, Hasson A, Ling W.

J Addict Med. 2013 Jan-Feb;7(1):33-8. doi: 10.1097/ADM.0b013e318277e92e.

29.

Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology.

Mooney LJ, Nielsen S, Saxon A, Hillhouse M, Thomas C, Hasson A, Stablein D, McCormack J, Lindblad R, Ling W.

Contemp Clin Trials. 2013 Mar;34(2):196-204. doi: 10.1016/j.cct.2012.11.002. Epub 2012 Nov 16.

30.

Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial.

Saxon AJ, Ling W, Hillhouse M, Thomas C, Hasson A, Ang A, Doraimani G, Tasissa G, Lokhnygina Y, Leimberger J, Bruce RD, McCarthy J, Wiest K, McLaughlin P, Bilangi R, Cohen A, Woody G, Jacobs P.

Drug Alcohol Depend. 2013 Feb 1;128(1-2):71-6. doi: 10.1016/j.drugalcdep.2012.08.002. Epub 2012 Aug 22.

31.

Periorbital syringoma treated with radiofrequency and carbon dioxide (CO2) laser in 5 patients.

Hasson A, Farias MM, Nicklas C, Navarrete C.

J Drugs Dermatol. 2012 Jul;11(7):879-80.

PMID:
22777235
32.

Topical photodynamic therapy with methylaminolevulinate for the treatment of actinic keratosis and reduction of photodamage in organ transplant recipients: a case-series of 16 patients.

Hasson A, Navarrete-Dechent C, Nicklas C, de la Cruz C.

Indian J Dermatol Venereol Leprol. 2012 Jul-Aug;78(4):448-53. doi: 10.4103/0378-6323.98075.

33.

Branching ratios for the reaction of selected carbonyl-containing peroxy radicals with hydroperoxy radicals.

Hasson AS, Tyndall GS, Orlando JJ, Singh S, Hernandez SQ, Campbell S, Ibarra Y.

J Phys Chem A. 2012 Jun 21;116(24):6264-81. doi: 10.1021/jp211799c. Epub 2012 Apr 17.

PMID:
22483091
34.

Efficacy of topical photodynamic therapy for keratoacanthomas: a case-series of four patients.

Farias MM, Hasson A, Navarrete C, Nicklas C, Garcia-Huidobro I, Gonzalez S.

Indian J Dermatol Venereol Leprol. 2012 Mar-Apr;78(2):172-4. doi: 10.4103/0378-6323.93634.

35.

Accelerated wound closure in a diabetic mouse model after exposure to phenanthrenequinone.

Polack G, McCray V, Tyner T, Kane S, Vu K, Yamaguchi K Jr, Merriman J, Ishimoto M, Hasson A, Sian K, Yamaguchi KT.

Ann Plast Surg. 2013 Jun;70(6):720-5. doi: 10.1097/SAP.0b013e3182326ed7.

PMID:
22395047
36.

Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.

Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, Griffin ML, Gourevitch MN, Haller DL, Hasson AL, Huang Z, Jacobs P, Kosinski AS, Lindblad R, McCance-Katz EF, Provost SE, Selzer J, Somoza EC, Sonne SC, Ling W.

Arch Gen Psychiatry. 2011 Dec;68(12):1238-46. doi: 10.1001/archgenpsychiatry.2011.121. Epub 2011 Nov 7.

37.

Method development for the measurement of quinone levels in urine.

Lim D, Ikeda A, Vu KK, Yamaguchi KT, Tyner TR, Hasson AS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Nov 15;879(30):3592-8. doi: 10.1016/j.jchromb.2011.09.051. Epub 2011 Oct 6.

PMID:
22024390
38.

Participant characteristics and buprenorphine dose.

Hillhouse M, Canamar CP, Doraimani G, Thomas C, Hasson A, Ling W.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):453-9. doi: 10.3109/00952990.2011.596974.

39.

Model for the regulation of Arabidopsis thaliana leaf margin development.

Bilsborough GD, Runions A, Barkoulas M, Jenkins HW, Hasson A, Galinha C, Laufs P, Hay A, Prusinkiewicz P, Tsiantis M.

Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3424-9. doi: 10.1073/pnas.1015162108. Epub 2011 Feb 7.

40.

Evolution and diverse roles of the CUP-SHAPED COTYLEDON genes in Arabidopsis leaf development.

Hasson A, Plessis A, Blein T, Adroher B, Grigg S, Tsiantis M, Boudaoud A, Damerval C, Laufs P.

Plant Cell. 2011 Jan;23(1):54-68. doi: 10.1105/tpc.110.081448. Epub 2011 Jan 21.

41.

Addition of chitosan may improve the treatment efficacy of triple bandage and compression in the treatment of venous leg ulcers.

Sandoval M, Albornoz C, Muñoz S, Fica M, García-Huidobro I, Mertens R, Hasson A.

J Drugs Dermatol. 2011 Jan;10(1):75-9.

PMID:
21197527
42.
43.

(CH3)3COOH (tert-butyl hydroperoxide): OH reaction rate coefficients between 206 and 375 K and the OH photolysis quantum yield at 248 nm.

Baasandorj M, Papanastasiou DK, Talukdar RK, Hasson AS, Burkholder JB.

Phys Chem Chem Phys. 2010 Oct 14;12(38):12101-11. doi: 10.1039/c0cp00463d. Epub 2010 Aug 9.

PMID:
20694250
44.

Leaving the meristem behind: the genetic and molecular control of leaf patterning and morphogenesis.

Hasson A, Blein T, Laufs P.

C R Biol. 2010 Apr;333(4):350-60. doi: 10.1016/j.crvi.2010.01.013. Epub 2010 Mar 12. Review.

PMID:
20371110
45.

From research to the real world: buprenorphine in the decade of the Clinical Trials Network.

Ling W, Jacobs P, Hillhouse M, Hasson A, Thomas C, Freese T, Sparenborg S, McCarty D, Weiss R, Saxon A, Cohen A, Straus M, Brigham G, Liu D, McLaughlin P, Tai B.

J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S53-60. doi: 10.1016/j.jsat.2010.01.009.

46.

A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology.

Weiss RD, Potter JS, Provost SE, Huang Z, Jacobs P, Hasson A, Lindblad R, Connery HS, Prather K, Ling W.

Contemp Clin Trials. 2010 Mar;31(2):189-99. doi: 10.1016/j.cct.2010.01.003. Epub 2010 Jan 29.

47.

Leaf development: what it needs to be complex.

Blein T, Hasson A, Laufs P.

Curr Opin Plant Biol. 2010 Feb;13(1):75-82. doi: 10.1016/j.pbi.2009.09.017. Epub 2009 Oct 23. Review.

PMID:
19853496
48.

Dynamic refolding of IFN-gamma mRNA enables it to function as PKR activator and translation template.

Cohen-Chalamish S, Hasson A, Weinberg D, Namer LS, Banai Y, Osman F, Kaempfer R.

Nat Chem Biol. 2009 Dec;5(12):896-903. doi: 10.1038/nchembio.234. Epub 2009 Oct 4.

PMID:
19801993
49.

Buprenorphine tapering schedule and illicit opioid use.

Ling W, Hillhouse M, Domier C, Doraimani G, Hunter J, Thomas C, Jenkins J, Hasson A, Annon J, Saxon A, Selzer J, Boverman J, Bilangi R.

Addiction. 2009 Feb;104(2):256-65. doi: 10.1111/j.1360-0443.2008.02455.x.

50.

Correlates of hospitalization for alcohol-using methadone-maintained persons with physical health problems.

Nyamathi A, Compton P, Cohen A, Marfisee M, Shoptaw S, Greengold B, de Castro V, Reaves M, Hasson A, George D, Leake B.

West J Nurs Res. 2009 Jun;31(4):525-43. doi: 10.1177/0193945908328784. Epub 2009 Jan 7.

Supplemental Content

Loading ...
Support Center